These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 32884149)

  • 1. Author Correction: A co-clinical approach identifies mechanisms and potential therapies for androgen deprivation resistance in prostate cancer.
    Lunardi A; Ala U; Epping MT; Salmena L; Clohessy JG; Webster KA; Wang G; Mazzucchelli R; Bianconi M; Stack EC; Lis R; Patnaik A; Cantley LC; Bubley G; Cordon-Cardo C; Gerald WL; Montironi R; Signoretti S; Loda M; Nardella C; Pandolfi PP
    Nat Genet; 2020 Oct; 52(10):1132. PubMed ID: 32884149
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Author Correction: LRIG1 is a pleiotropic androgen receptor-regulated feedback tumor suppressor in prostate cancer.
    Li Q; Liu B; Chao HP; Ji Y; Lu Y; Mehmood R; Jeter C; Chen T; Moore JR; Li W; Liu C; Rycaj K; Tracz A; Kirk J; Calhoun-Davis T; Xiong J; Deng Q; Huang J; Foster BA; Gokhale A; Chen X; Tang DG
    Nat Commun; 2020 Jun; 11(1):2895. PubMed ID: 32499578
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Author Correction: An exome-wide rare variant analysis of Korean men identifies three novel genes predisposing to prostate cancer.
    Oh JJ; Shivakumar M; Miller J; Verma S; Lee H; Hong SK; Lee SE; Lee Y; Lee SJ; Sung J; Kim D; Byun SS
    Sci Rep; 2020 Feb; 10(1):2481. PubMed ID: 32034279
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Author Correction: Co-targeting PIM and PI3K/mTOR using multikinase inhibitor AUM302 and a combination of AZD-1208 and BEZ235 in prostate cancer.
    Luszczak S; Simpson BS; Stopka-Farooqui U; Sathyadevan VK; Echeverria LMC; Kumar C; Costa H; Haider A; Freeman A; Jameson C; Ratynska M; Ben-Salha I; Sridhar A; Shaw G; Kelly JD; Pye H; Gately KA; Whitaker HC; Heavey S
    Sci Rep; 2020 Nov; 10(1):19870. PubMed ID: 33177621
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Author Correction: Evaluation of T1 relaxation time in prostate cancer and benign prostate tissue using a Modified Look-Locker inversion recovery sequence.
    Baur ADJ; Hansen CM; Rogasch J; Posch H; Elezkurtaj S; Maxeiner A; Erb-Eigner K; Makowski MR
    Sci Rep; 2020 Mar; 10(1):5249. PubMed ID: 32184409
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Author Correction: Anticancer polymers designed for killing dormant prostate cancer cells.
    Takahashi H; Yumoto K; Yasuhara K; Nadres ET; Kikuchi Y; Buttitta L; Taichman RS; Kuroda K
    Sci Rep; 2019 Nov; 9(1):17455. PubMed ID: 31767898
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Author Correction: The evolutionary history of lethal metastatic prostate cancer.
    Gundem G; Van Loo P; Kremeyer B; Alexandrov LB; Tubio JMC; Papaemmanuil E; Brewer DS; Kallio HML; Hägnäs G; Annala M; Kivinummi K; Goody V; Latimer C; O'Meara S; Dawson KJ; Isaacs W; Emmert-Buck MR; Nykter M; Foster C; Kote-Jarai Z; Easton D; Whitaker HC; ; Neal DE; Cooper CS; Eeles RA; Visakorpi T; Campbell PJ; McDermott U; Wedge DC; Bova GS
    Nature; 2020 Aug; 584(7820):E18. PubMed ID: 32728210
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Author Correction: An integrated multi-omics approach identifies epigenetic alterations associated with Alzheimer's disease.
    Nativio R; Lan Y; Donahue G; Sidoli S; Berson A; Srinivasan AR; Shcherbakova O; Amlie-Wolf A; Nie J; Cui X; He C; Wang LS; Garcia BA; Trojanowski JQ; Bonini NM; Berger SL
    Nat Genet; 2020 Nov; 52(11):1266. PubMed ID: 33033384
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Author Correction: FOXA1 mutations alter pioneering activity, differentiation and prostate cancer phenotypes.
    Adams EJ; Karthaus WR; Hoover E; Liu D; Gruet A; Zhang Z; Cho H; DiLoreto R; Chhangawala S; Liu Y; Watson PA; Davicioni E; Sboner A; Barbieri CE; Bose R; Leslie CS; Sawyers CL
    Nature; 2020 Sep; 585(7826):E20. PubMed ID: 32895534
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Author Correction: Virtual clinical trials identify effective combination therapies in ovarian cancer.
    Kozłowska E; Vallius T; Hynninen J; Hietanen S; Färkkilä A; Hautaniemi S
    Sci Rep; 2020 Jul; 10(1):12531. PubMed ID: 32694595
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Author Correction: MUC1-C regulates lineage plasticity driving progression to neuroendocrine prostate cancer.
    Yasumizu Y; Rajabi H; Jin C; Hata T; Pitroda S; Long MD; Hagiwara M; Li W; Hu Q; Liu S; Yamashita N; Fushimi A; Kui L; Samur M; Yamamoto M; Zhang Y; Zhang N; Hong D; Maeda T; Kosaka T; Wong KK; Oya M; Kufe D
    Nat Commun; 2020 Feb; 11(1):1095. PubMed ID: 32094369
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Author Correction: Aberrant ERG expression cooperates with loss of PTEN to promote cancer progression in the prostate.
    Carver BS; Tran J; Gopalan A; Chen Z; Shaikh S; Carracedo A; Alimonti A; Nardella C; Varmeh S; Scardino PT; Cordon-Cardo C; Gerald W; Pandolfi PP
    Nat Genet; 2020 Sep; 52(9):984. PubMed ID: 32820258
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Author Correction: Hsp70 and Hsp40 inhibit an inter-domain interaction necessary for transcriptional activity in the androgen receptor.
    Eftekharzadeh B; Banduseela VC; Chiesa G; Martínez-Cristóbal P; Rauch JN; Nath SR; Schwarz DMC; Shao H; Marin-Argany M; Di Sanza C; Giorgetti E; Yu Z; Pierattelli R; Felli IC; Brun-Heath I; García J; Nebreda ÁR; Gestwicki JE; Lieberman AP; Salvatella X
    Nat Commun; 2019 Oct; 10(1):4605. PubMed ID: 31591399
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Author Correction: Evaluation of Radiation dosimetry of
    Zhang J; Zhang J; Xu X; Lu L; Hu S; Liu C; Cheng J; Song S; Zhang Y; Shi LQ
    Sci Rep; 2020 Oct; 10(1):18494. PubMed ID: 33097773
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Author Correction: Phonological network fluency identifies phonological restructuring through mental search.
    Neergaard KD; Luo J; Huang CR
    Sci Rep; 2020 Jan; 10(1):596. PubMed ID: 31937800
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Author Correction: Genomic Prediction of 16 Complex Disease Risks Including Heart Attack, Diabetes, Breast and Prostate Cancer.
    Lello L; Raben TG; Yong SY; Tellier LCAM; Hsu SDH
    Sci Rep; 2019 Nov; 9(1):17515. PubMed ID: 31748697
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Author Correction: Genetic alterations in the 3q26.31-32 locus confer an aggressive prostate cancer phenotype.
    Simpson BS; Camacho N; Luxton HJ; Pye H; Finn R; Heavey S; Pitt J; Moore CM; Whitaker HC
    Commun Biol; 2020 Oct; 3(1):570. PubMed ID: 33033409
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Author Correction: Association of imputed prostate cancer transcriptome with disease risk reveals novel mechanisms.
    Emami NC; Kachuri L; Meyers TJ; Das R; Hoffman JD; Hoffmann TJ; Hu D; Shan J; Feng FY; Ziv E; Van Den Eeden SK; Witte JS
    Nat Commun; 2019 Aug; 10(1):3948. PubMed ID: 31462633
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Author Correction: A recellularized human colon model identifies cancer driver genes.
    Chen HJ; Wei Z; Sun J; Bhattacharya A; Savage DJ; Serda R; Mackeyev Y; Curley SA; Bu P; Wang L; Chen S; Cohen-Gould L; Huang E; Shen X; Lipkin SM; Copeland NG; Jenkins NA; Shuler ML
    Nat Biotechnol; 2019 Jul; 37(7):820. PubMed ID: 31160724
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Author Correction: Gastroesophageal reflux GWAS identifies risk loci that also associate with subsequent severe esophageal diseases.
    An J; Gharahkhani P; Law MH; Ong JS; Han X; Olsen CM; Neale RE; Lai J; Vaughan TL; Gockel I; Thieme R; Böhmer AC; Jankowski J; Fitzgerald RC; Schumacher J; Palles C; ; ; Whiteman DC; MacGregor S
    Nat Commun; 2019 Dec; 10(1):5617. PubMed ID: 31796739
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.